在清细胞细胞癌中,BBOX1抑制TBK1-mTORC1瘤信号传递
Chengheng Liao1, Lianxin Hu2,3, Liwei Jia2
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Chengheng.Liao@UTSouthwestern.edu.
Nature communications
|February 11, 2025
概括
γ-butyrobetaine氧酶1 (BBOX1) 作为清细胞脏细胞癌 (ccRCC) 的瘤抑制剂. 恢复BBOX1通过通过BBOX1-DCLK2-TBK1轴准代谢途径来抑制ccRCC的生长.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢疾病 代谢疾病
背景情况:
- 清细胞细胞癌 (ccRCC) 是一种代谢性恶性瘤,起源于近端卷状管 (PCT) 表皮细胞.
- 在ccRCC病原体的启动信号事件尚未完全理解.
- γ-butyrobetaine hydroxylase 1 (BBOX1) 是一种关键的酶,主要表达在PCT细胞中.
研究的目的:
- 在ccRCC中识别新的瘤抑制剂.
- 阐明BBOX1在ccRCC发育和进展中的作用.
- 为了研究BBOX1-介导瘤抑制的基础分子机制.
主要方法:
- 在ccRCC组织中分析BBOX1表达.
- 功能性研究涉及BBOX1在ccRCC细胞和异种移植中的恢复.
- 转录学分析以确定受影响的信号通路.
- 研究了BBOX1,TANK结合激酶1 (TBK1) 和双类激酶2 (DCLK2) 之间的相互作用.
主要成果:
- 在ccRCC恶性转变过程中,BBOX1的表达失去了.
- 恢复BBOX1降低了ccRCC细胞的活力,并抑制了瘤的生长.
- BBOX1抑制了关键的代谢途径,包括mTORC1信号和糖解.
- BBOX1通过破坏DCLK2-TBK1相互作用来抑制ccRCC,从而防止TBK1的激活.
结论:
- 在ccRCC中,BBOX1作为瘤抑制剂起作用.
- BBOX1-DCLK2-TBK1轴是ccRCC代谢失调的一个关键机制.
- 针对这一轴可能为ccRCC提供潜在的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


